About
11.99USD-0.47 -3.77%
Closed • Updated at 23:30 GMT+00:00Market Cap$13.98M
Volume83.9K
Beta2.47
RSI62.93
Ernexa Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 20 2026
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
May 6 2026
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
Apr 30 2026
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 20 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Feb 6 2026
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
Community Chat
Ask AI
Try asking
Translate